Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01681433
Title OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone
Recruitment Terminated
Gender male
Phase Phase II
Variant Requirements No
Sponsors Costantine Albany
Indications
Therapies
Age Groups: adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Prostate Oncology Specialists, Inc. Marina Del Rey California 90292 United States Details
IU Health Bloomington Hospital Bloomington Indiana 47403 United States Details
IU Health Goshen Hospital Goshen Indiana 46527 United States Details
Indiana University Melvin and Bren Simon Cancer Center Indianapolis Indiana 46202 United States Details
IU Health Central Indiana Cancer Centers Indianapolis Indiana 46219 United States Details
Northern Indiana Cancer Research Consortium South Bend Indiana 46601 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02115 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
University of New Mexico Cancer Center: Albuquerque Albuquerque New Mexico 87131 United States Details
Virginia Oncology Associates Norfolk Virginia 23502 United States Details
Alberta Health Services: Tom Baker Cancer Centre Calgary Alberta T2N 4N2 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BC Cancer Agency Vancouver British Columbia V5Z 4E6 Canada Details
Cancer Care Manitoba Winnipeg Manitoba R3E 0V9 Canada Details
Juravinski Cancer Centre Hamilton Ontario L8V 5C2 Canada Details
Centre Hospitalier de l'Université de Montréal Montreal Quebec H2L 4M1 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field